News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2025 |
Sales Effectiveness
Advertisement

Ricardo Rojo Cella, MD

Advertisement

Articles by Ricardo Rojo Cella, MD

Janssen, Johns Hopkins Partner on Dermatology Ethnic Skin Program

ByRicardo Rojo Cella, MD,Crystal Aguh, MD
April 7th 2023

Janssen, Johns Hopkins Dermatology’s Ethnic Skin Fellowship Program partnership focuses on improving clinical care and advancing research for skin-of-color patients.

Advertisement

Latest Updated Articles

  • Janssen, Johns Hopkins Partner on Dermatology Ethnic Skin Program
    Janssen, Johns Hopkins Partner on Dermatology Ethnic Skin Program

    April 7th 2023



Advertisement
Advertisement

Trending on PharmExec

1

Pfizer Receives Unsolicited Mini-Tender Offer for 1 Million Shares from Tutanota: Report

2

Gilead Sciences Enters $2.1 Billion Definitive Agreement to Acquire Ouro Medicines

3

Pharmaceutical Executive Daily: Pfizer Warns Shareholders to Reject Mini-Tender Offer

4

Why CMS Is Tightening ASP Reporting and What Manufacturers Must Get Right

5

Why Do Most Pharma Shippers and 3PLs Not Possess the Right Technology to Move From Forecasting to True Agility?

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us